Timing of Direct Oral Anticoagulant Resumption After Outpatient Colonoscopy and Risk of Gastrointestinal Bleeding and Thromboembolic Events
Clinical Gastroenterology and Hepatology · 2026-03
DOI: 10.1016/j.cgh.2026.03.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-03. Verfasst von Lawrence Jun Leung und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Kaiser Permanente San Francisco Medical Center, San Francisco, California. Electronic address: Lawrence.J.Leung@kp.or…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Cancer Institute Division of Cancer Epidemiology and Genetics, National Cancer Institute, Kaiser Permanente LLC.
Abstract (Originalsprache)
BACKGROUND & AIMS: There is limited direct evidence for when to restart direct oral anticoagulants (DOACs) after colonoscopy. Therefore, we evaluated the risks of post-colonoscopy gastrointestinal (GI) bleeding and thromboembolic events according to the timing of DOAC resumption. METHODS: We identified 7798 Kaiser Permanente Northern California members aged ≥18 years who underwent outpatient colonoscopy between 2013 and 2022 while prescribed dabigatran, rivaroxaban, or apixaban and had documented instructions regarding DOAC resumption. Patients were categorized as early (
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Kaiser Permanente San Francisco Medical Center, San Francisco, California. Electronic address: Lawrence.J.Leung@kp.org.
- Division of Research, Kaiser Permanente Northern California, Pleasanton, California.
- Department of Gastroenterology, Kaiser Permanente San Francisco Medical Center, San Francisco, California.
- Department of Gastroenterology, Kaiser Permanente San Francisco Medical Center, San Francisco, California; Division of Research, Kaiser Permanente Northern California, Pleasanton, California.
Förderung
- National Cancer Institute Division of Cancer Epidemiology and Genetics
- National Cancer Institute
- Kaiser Permanente LLC
Zitieren
APA
Leung, L. J., Merchant, S. A., Thomas, P., Jensen, C. D., Koripella, P., Bal, A., Oh, A., Leung, M., & Lee, J. K. (2026). Timing of Direct Oral Anticoagulant Resumption After Outpatient Colonoscopy and Risk of Gastrointestinal Bleeding and Thromboembolic Events. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2026.03.005
Vancouver
Leung LJ, Merchant SA, Thomas P, Jensen CD, Koripella P, Bal A, et al. Timing of Direct Oral Anticoagulant Resumption After Outpatient Colonoscopy and Risk of Gastrointestinal Bleeding and Thromboembolic Events. Clinical Gastroenterology and Hepatology. 2026. doi:10.1016/j.cgh.2026.03.005
BibTeX
@article{Leung2026,
author = {Leung, Lawrence Jun and Merchant, Sophie A and Thomas, Prakash and Jensen, Christopher D and Koripella, Pradeep and Bal, Amanat and Oh, Aaron and Leung, Marcia and Lee, Jeffrey K},
title = {Timing of Direct Oral Anticoagulant Resumption After Outpatient Colonoscopy and Risk of Gastrointestinal Bleeding and Thromboembolic Events},
journal = {Clinical Gastroenterology and Hepatology},
year = {2026},
doi = {10.1016/j.cgh.2026.03.005}
}
EUVIMED